Yaharn Su

FDA investigator · also recorded as Mad Pct Yaharn Su

Appears on 9 documents from 2023 to 2026, most often at sites in Maryland. Most often cites responsibilities of quality control unit (21 CFR 211.22).

9
Documents on file
4.6
Observations per 483
2023
First seen
2026
Most recent

What they cite most

From 37 observations

Activity by year

2023: 3, 2024: 3, 2025: 2, 2026: 1

Where

Maryland 3 · Virginia 2 · Florida 1 · New Jersey 1 · Pennsylvania 1 · West Virginia 1

Is Yaharn Su coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 ChemPacific CorporationApr 7, 2026 · Baltimore, Maryland
483 Form 483 · FEI 3004086743Aug 14, 2025 · Pittsburgh, Pennsylvania
483 B. Braun US Pharmaceutical Manufacturing LLCJan 31, 2025 · Daytona Beach, Florida
483 Annovex Pharma, Inc.Sep 6, 2024 · Lorton, Virginia
483 Diamond Chemical Co. IncMay 16, 2024 · East Rutherford, New Jersey
483 Eisai Inc.Apr 9, 2024 · Baltimore, Maryland
483 Granules Pharmaceuticals Inc.Dec 15, 2023 · Chantilly, Virginia

About this profile

What does Yaharn Su inspect?

Yaharn Su appears on 9 documents on file covering 9 sites, most often in Maryland.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.192 and 21 CFR 211.42(b).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Yaharn Su is dated Apr 7, 2026.